Long-term efficacy of reduced-intensity versus myeloablative conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: retrospective follow-up of an open-label, randomised phase 3 trial-Reference-Cited by-同舟云学术

Long-term efficacy of reduced-intensity versus myeloablative conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: retrospective follow-up of an open-label, randomised phase 3 trial

Published:2018-04 Issue:4 Volume:5 Page:e161-e169
ISSN:2352-3026
Container-title:The Lancet Haematology
language:en
Short-container-title:The Lancet Haematology

Author:

Fasslrinner Frederick,Schetelig Johannes,Burchert Andreas,Kramer Michael,Trenschel Rudolf,Hegenbart Ute,Stadler Michael,Schäfer-Eckart Kerstin,Bätzel Michael,Eich Hans,Stuschke Martin,Engenhart-Cabillic Rita,Krause Mechthild,Dreger Peter,Neubauer Andreas,Ehninger Gerhard,Beelen Dietrich,Berdel Wolfgang E,Siepmann Timo,Stelljes Matthias,Bornhäuser Martin

Publisher

Elsevier BV

Subject

Hematology

Reference29 articles.

1. Allogeneic transplantation versus chemotherapy as postremission therapy for acute myeloid leukemia: a prospective matched pairs analysis;Stelljes;J Clin Oncol,2014

2. Marrow transplantation for acute nonlymphoblastic leukemia in first remission using fractionated or single-dose irradiation;Thomas;Int J Radiat Oncol Biol Phys,1982

3. Long-term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hematologic malignancies;Sorror;JAMA,2011

4. Defining the intensity of conditioning regimens: working definitions;Bacigalupo;Biol Blood Marrow Transplant,2009

5. Reduced-intensity conditioning versus standard conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: a prospective, open-label randomised phase 3 trial;Bornhäuser;Lancet Oncol,2012

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Busulfan-fludarabine versus busulfan-cyclophosphamide for allogeneic transplant in acute myeloid leukemia: long term analysis of GITMO AML-R2 trial;Blood Cancer Journal;2024-08-21

2. How to Run a Successful Transplant Program in Older Patients with Myeloid Malignancies;Transplantation and Cellular Therapy;2024-08

3. Comparison of atrial fibrillation prevalence and in-hospital cardiovascular outcomes between patients undergoing allogeneic versus autologous hematopoietic stem cell transplantation: insights from the national inpatient sample;Scientific Reports;2024-07-22

4. Busulfan-Fludarabine Versus Busulfan-Cyclophosphamide for Allogeneic Transplant in Acute Myeloid Leukemia: Long Term Analysis of GITMO AML-R2 Trial;2024-07-18

5. Tacrolimus versus cyclosporine a combined with post-transplantation cyclophosphamide for AML In first complete remission: a study from the acute leukemia working party (EBMT);Bone Marrow Transplantation;2024-07-03